Bextra Contraindicated In CABG Surgery Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Labeling change to add "black box" for serious skin reactions incorporates post-surgery safety data, including results from two coronary artery bypass graft trials that show increased cardiovascular risk with Pfizer's COX-2 inhibitor.